AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2021
Nov 30, 2021
32538_dirs_2021-11-30_52023599-6e68-4306-b827-0c8c78827a46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2021-11-26
Reporting Person: SATO VICKI L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-26 | Common Stock | S | 15174 | $36.80 | Disposed | 1566266 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.
More from Vir Biotechnology, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26